Phase I study to determine the safety and pharmacokinetics of BAY 43-9006 in patients with advanced refractory solid tumors. Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Hirte, Holger
  • Moore, MJ
  • Oza, AM
  • Siu, LL
  • Harris, H
  • Maclean, M
  • Petrenciuc, O
  • Fiander, W
  • Lathia, C

publication date

  • November 2001